Bausch Health Cos., Inc. (BHC)
6.30
0.00 (0.00%)
USD |
NYSE |
Aug 28, 13:44
Bausch Health Cos. Debt to Equity Ratio : -11.73 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -11.73 |
| March 31, 2026 | -10.10 |
| December 31, 2025 | -38.05 |
| September 30, 2025 | -37.24 |
| June 30, 2025 | -28.45 |
| March 31, 2025 | -18.18 |
| December 31, 2024 | -17.08 |
| September 30, 2024 | -18.32 |
| June 30, 2024 | -18.43 |
| March 31, 2024 | -19.80 |
| December 31, 2023 | -22.11 |
| September 30, 2023 | -19.01 |
| June 30, 2023 | -31.00 |
| March 31, 2023 | -25.82 |
| December 31, 2022 | -30.35 |
| September 30, 2022 | -40.41 |
| June 30, 2022 | -31.48 |
| March 31, 2022 | -107.26 |
| December 31, 2021 | -216.21 |
| September 30, 2021 | -109.60 |
| June 30, 2021 | -34.12 |
| March 31, 2021 | -120.50 |
| December 31, 2020 | 45.24 |
| September 30, 2020 | 41.47 |
| June 30, 2020 | 51.39 |
| Date | Value |
|---|---|
| March 31, 2020 | 33.98 |
| December 31, 2019 | 24.64 |
| September 30, 2019 | 9.609 |
| June 30, 2019 | 9.366 |
| March 31, 2019 | 9.088 |
| December 31, 2018 | 8.893 |
| September 30, 2018 | 7.844 |
| June 30, 2018 | 7.236 |
| March 31, 2018 | 5.712 |
| December 31, 2017 | 4.350 |
| September 30, 2017 | 5.095 |
| June 30, 2017 | 7.240 |
| March 31, 2017 | 7.334 |
| December 31, 2016 | 9.471 |
| September 30, 2016 | 7.306 |
| June 30, 2016 | 5.866 |
| March 31, 2016 | 5.654 |
| December 31, 2015 | 5.262 |
| September 30, 2015 | 4.869 |
| June 30, 2015 | 4.799 |
| March 31, 2015 | 4.033 |
| December 31, 2014 | 2.886 |
| September 30, 2014 | 3.177 |
| June 30, 2014 | 3.295 |
| March 31, 2014 | 3.416 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| InMed Pharmaceuticals, Inc. | 0.061 |
| NervGen Pharma Corp. | 0.00 |
| Milestone Pharmaceuticals, Inc. | 7.785 |
| Clearmind Medicine, Inc. | 0.0075 |
| Lexaria Bioscience Corp. | 0.0183 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 24.79B |
| Total Liabilities (Quarterly) | 25.60B |
| Shareholders Equity (Quarterly) | -1.771B |
| Current Ratio | 1.435 |
| Net Debt Paydown Yield | 7.93% |